Digestive / Research profile
07 / 13Tirzepatide
Dual GIP and GLP-1 receptor agonist
Oral strip is not an FDA-approved medicine
What is Tirzepatide?
Tirzepatide is the active ingredient in FDA-approved prescription injectable medicines. One molecule activates two receptor types, GIP and GLP-1. Evidence for the approved injectable medicines does not apply to an oral strip.
The important distinction
Neuvéra offers this formula by subscription only, as Metabolic Strips and in the Metabolic Balance Routine. It is not the prescription medicine, and no equivalence to it is claimed.
Explore matching Neuvera products
Metabolic StripsOral-dissolving strip · subscription onlyOut of stock · $279.00 per box, subscription onlyLeave your email and we’ll tell you when Metabolic Strips is available.
Metabolic Balance RoutineTwo-product oral-strip routineIncludes: Metabolic Strips + NAD+ oral stripsOut of stock · $299.00 per set, subscription onlyLeave your email and we’ll tell you when Metabolic Balance Routine is available.
Matches identify listed ingredients, not proven effects. Prices are current list prices. Read the full product label and formulation distinctions.
